Clinical Trial Update: A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update announcing a Phase 1/2 study of SHR2554 in combination with chemotherapy for treatment-naïve peripheral T-cell lymphoma, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• SHR2554

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Peripheral T-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING